Patents by Inventor Nicholas Jon Boylan

Nicholas Jon Boylan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same
    Publication number: 20210259982
    Abstract: The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: February 18, 2021
    Publication date: August 26, 2021
    Applicant: Pfizer Inc.
    Inventors: Allen Thomas Horhota, Young-Ho Song, Ujjwal Chaitanya Joshi, Nicholas Jon Boylan, Matthew John Simmons
  • Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
    Patent number: 10952972
    Abstract: The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: March 23, 2021
    Assignee: Pfizer Inc.
    Inventors: Allen Thomas Horhota, Young-Ho Song, Ujjwal Chaitanya Joshi, Nicholas Jon Boylan, Matthew John Simmons
  • Methods of Controlling Morphology of Polymeric Nanoparticles
    Publication number: 20190269617
    Abstract: The present disclosure generally relates to methods of making nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol.
    Type: Application
    Filed: March 6, 2019
    Publication date: September 5, 2019
    Applicant: Pfizer Inc.
    Inventors: Donald Parsons, Mir Mukkaram Ali, Nicholas Jon Boylan
  • Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same
    Publication number: 20190091164
    Abstract: The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.
    Type: Application
    Filed: May 24, 2018
    Publication date: March 28, 2019
    Applicant: Pfizer Inc.
    Inventors: Allen Thomas Horhota, Young-Ho Song, Ujjwal Chaitanya Joshi, Nicholas Jon Boylan, Matthew John Simmons